Total Funding
61
77
Total FundingSeries A raised
Growth Score
-9 pts
Heat Score
15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
7104
Cardiosense is a digital biomarker platform that provides multi-sensor devices and proprietary algorithms to detect early signs of diseases.
- Luke Neill: VP, Clinical Affairs
- John Martin: Executive Vice President and Chief Medical OfficerPast Role: Butterfly Network, Chief Medical Officer
About the Company
Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. They mine raw biosignals for unprecedented visibility into cardiac functions. They also develop an advanced signal processing pipeline to identify pre-symptomatic markers of cardiac disease.
